Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Urinary Tract Carcinoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Genitourinary System Neoplasm
Urinary System Neoplasm
Malignant Urinary System Neoplasm
Malignant Urinary Tract Neoplasm
Urinary Tract Carcinoma

Subtype

Urinary Tract Carcinoma

CI-CAN-00007014Explore in graph →

326 active trials11 approved drugs23 evidence items

NCIt: C192669

Overview
Statistics
Survival
Genomics24
Variants & evidence23
Drugs17
Trials852
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

852 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 326
Recruiting: 177
Ph III recruiting: 26
Growth YoY: +28.6%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 44.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (127)

StatusAll Active (any)Recruiting 225 Completed 217 Active Not Recruiting 106 Terminated 103 Unknown 98 Not Yet Recruiting 58 Withdrawn 34 Enrolling By Invitation 6 Available 3 Approved For Marketing 2

PhaseAll Early Phase 1 20 N/A 89 Phase 1 241 Phase 2 372 Phase 3 65 Phase 4 11

No study matches these filters